CHIRICOZZI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 7.246
AS - Asia 927
EU - Europa 873
Continente sconosciuto - Info sul continente non disponibili 204
SA - Sud America 125
AF - Africa 23
OC - Oceania 3
Totale 9.401
Nazione #
US - Stati Uniti d'America 7.199
SG - Singapore 375
CN - Cina 235
IT - Italia 157
RU - Federazione Russa 144
BR - Brasile 105
DE - Germania 93
UA - Ucraina 84
FR - Francia 80
HK - Hong Kong 77
VN - Vietnam 67
SE - Svezia 63
IE - Irlanda 55
GB - Regno Unito 53
PL - Polonia 44
BD - Bangladesh 37
IN - India 37
CA - Canada 32
FI - Finlandia 29
NL - Olanda 25
JP - Giappone 23
KR - Corea 19
ES - Italia 11
AR - Argentina 10
MX - Messico 8
TR - Turchia 8
MY - Malesia 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
AT - Austria 6
RO - Romania 6
CH - Svizzera 5
ID - Indonesia 5
KG - Kirghizistan 5
LT - Lituania 5
PH - Filippine 5
MA - Marocco 4
PK - Pakistan 4
AU - Australia 3
BE - Belgio 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
NI - Nicaragua 2
OM - Oman 2
RS - Serbia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BB - Barbados 1
CG - Congo 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 9.202
Città #
Woodbridge 2.027
Wilmington 1.736
Houston 1.515
Singapore 252
Fairfield 218
Ashburn 177
Chandler 145
Ann Arbor 126
San Jose 106
Seattle 83
Hong Kong 77
Cambridge 76
Beijing 68
Jacksonville 68
Dearborn 64
New York 63
Dublin 54
Council Bluffs 50
Medford 45
Rome 38
Kraków 37
The Dalles 37
Zhengzhou 36
Santa Clara 34
Los Angeles 29
Ho Chi Minh City 24
Dallas 23
Tokyo 23
Buffalo 22
Lawrence 21
Hanoi 18
Lauterbourg 18
Milan 15
Moscow 15
Munich 15
San Diego 15
São Paulo 14
Amsterdam 13
Menlo Park 12
Montreal 11
Norwalk 11
Redondo Beach 10
Shanghai 9
Chicago 8
Helsinki 8
Palo Alto 8
Toronto 8
Columbus 7
Hefei 7
Nanjing 7
Poplar 7
Warsaw 7
Boardman 6
Brooklyn 6
Chennai 6
Denver 6
Detroit 6
Dhaka 6
Frankfurt am Main 6
Johannesburg 6
Kunming 6
Orem 6
London 5
Mumbai 5
Phoenix 5
Bari 4
Engelhard 4
Fuzhou 4
Nanchang 4
Philadelphia 4
Redwood City 4
San Antonio 4
Verona 4
Boston 3
Brussels 3
Catania 3
Elk Grove Village 3
Esslingen am Neckar 3
Florence 3
Fortaleza 3
Goiânia 3
Guangzhou 3
Ludhiana 3
Manchester 3
Mexico City 3
Newark 3
Paris 3
Pune 3
Salt Lake City 3
Trieste 3
Turin 3
Vienna 3
Accra 2
Ankara 2
Araguari 2
Araçatuba 2
Atlanta 2
Auburn Hills 2
Basel 2
Belgrade 2
Totale 7.697
Nome #
Efficacy and safety of infliximab in psoriatic patients over the age of 65 557
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 544
Apremilast for the treatment of psoriasis. 482
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 482
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 458
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 454
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 450
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 426
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 421
Quality-of-life impairment in hidradenitis suppurativa 414
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 409
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 401
Immunologic biomarkers for clinical and therapeutic management of psoriasis 382
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 374
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 372
Tofacitinib for the treatment of moderate-to-severe psoriasis 363
Biomolecular index of therapeutic efficacy in psoriasis treated by anti-TNF alpha agents. 348
Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study 342
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry 339
Assessement of disease severity and treatment effectiveness in hidradenitis suppurtiva 338
Alexithymia affects patients with hidradenitis suppurativa 315
Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study 128
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 117
Anogenital involvement: Clinical sign of severity in hidradenitis suppurativa 100
Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab 88
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 82
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 80
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 69
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 66
Totale 9.401
Categoria #
all - tutte 22.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022176 0 0 21 13 8 19 10 8 14 20 17 46
2022/2023323 27 29 15 49 29 66 24 18 36 3 13 14
2023/2024177 19 1 10 5 13 39 8 16 4 15 7 40
2024/2025614 23 133 65 66 14 41 73 30 35 55 55 24
2025/20261.188 94 50 141 153 106 30 149 148 113 98 53 53
2026/2027170 81 45 44 0 0 0 0 0 0 0 0 0
Totale 9.401